A new nonNMDA antagonist modifies the local cerebral glucose utilization in kainate-induced generalized seizure

Neurological Research

Volumn 19, Issue 5, 1997, Pages 545-550

  Shiraishi, Kazuya ^a,b  

^a Department of Neurosurgery   (Japan)

^b Soga Clinic   (Japan)

Author keywords

2 DG; Hippocampus; Kainate; MK 801; NonNMDA antagonist; YM90K

Indexed keywords

6 (1 IMIDAZOLYL) 7 NITRO 2,3 QUINOXALINEDIONE; AMPA RECEPTOR ANTAGONIST; DEOXYGLUCOSE; DIZOCILPINE; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE UTILIZATION; GRAND MAL SEIZURE; HIPPOCAMPUS; INTRAVENOUS DRUG ADMINISTRATION; NERVE CELL NETWORK; NONHUMAN; RAT;

EID: 0030982471     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1080/01616412.1997.11740855     Document Type: Article

References (6)

1. Shimizu-Sasamata M, Kawasaki-Yatsugi S, Okada M, et al. YM90K: Pharamacological characterization as a selective and potent α-amino-3-hydroxy-5-methylisoxazole-4-propionate/Kainate receptor antagonist. J Pharmacol Exp Ther 1996; 276: 84-92
2. Watkins JC. Excitatory amino acids. In: McGeer EG, Olney JW, McGeer PL, eds. Kainic Acids as a Tool in Neurobiology, New York: Raven Press, 1987: pp. 37-69
3. Shiraishi K, Nakazawa S, Ito H. Zinc enhances kainate neurotoxicity in the rat brain. Neurol Res 1993; 15: 113-116
4. Shiraishi K, Sharp FR, Simon RP. Sequential metabolic changes in rat brain following middle cerebral artery occlusion: A 2-deoxy-glucose study. J Cereb Blood Flow Metab 1989; 9: 765-773
5. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure and normal values in the conscious and anesthetized albino rat. J Neurochem 1977; 28: 897-916
6. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 1982; 239: 57-69